ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,039,857 | -31.4% | 113,132 | -8.9% | 0.04% | -26.0% |
Q2 2023 | $4,428,081 | +27.6% | 124,175 | -9.1% | 0.05% | +22.0% |
Q1 2023 | $3,471,596 | -38.3% | 136,677 | -1.5% | 0.04% | -41.4% |
Q4 2022 | $5,629,890 | +25.1% | 138,804 | +1.9% | 0.07% | +14.8% |
Q3 2022 | $4,501,000 | -4.7% | 136,195 | +1.5% | 0.06% | 0.0% |
Q2 2022 | $4,725,000 | -27.8% | 134,205 | -5.7% | 0.06% | -12.9% |
Q1 2022 | $6,546,000 | -30.2% | 142,328 | +0.7% | 0.07% | -26.3% |
Q4 2021 | $9,375,000 | +6.9% | 141,403 | +0.6% | 0.10% | +9.2% |
Q3 2021 | $8,773,000 | -24.0% | 140,520 | +0.8% | 0.09% | -23.7% |
Q2 2021 | $11,546,000 | +3.2% | 139,409 | -17.3% | 0.11% | -2.6% |
Q1 2021 | $11,183,000 | -16.4% | 168,640 | -3.3% | 0.12% | -23.0% |
Q4 2020 | $13,383,000 | +73.6% | 174,414 | -2.5% | 0.15% | +47.6% |
Q3 2020 | $7,707,000 | +39.0% | 178,973 | +39.4% | 0.10% | +32.1% |
Q2 2020 | $5,544,000 | +33.6% | 128,363 | -11.0% | 0.08% | +13.0% |
Q1 2020 | $4,149,000 | -54.1% | 144,212 | +1.2% | 0.07% | -40.0% |
Q4 2019 | $9,035,000 | +9026.3% | 142,442 | +3943.2% | 0.12% | +11400.0% |
Q3 2019 | $99,000 | +10.0% | 3,523 | +3.2% | 0.00% | 0.0% |
Q2 2019 | $90,000 | – | 3,413 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
Tygh Capital Management, Inc. | 63,947 | $4,240,000 | 0.60% |